TuHURA Biosciences enters ATM agreement for up to $50M in common stock sales

TuHURA Biosciences, Inc./NV

Up to $50M of common stock may be sold through H.C. Wainwright as sales agent.
Wainwright receives 3.0% cash commission; company reimburses up to $75K in legal fees.
Proceeds will be used for working capital and general corporate purposes.
Either party may suspend or terminate the offering; no assurance any shares will be sold.
Registration statement on Form S-3 filed same day; sales begin once SEC declares effective.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.